High-dose vs standard-dose influenza vaccine in older adults according to diabetes status, a prespecified analysis of the FLUNITY-HD study
The FLUNITY-HD study, pooled analysis including 466,320 randomized older adults, demonstrated that high-dose inactivated influenza vaccine (HD-IIV) provided proven superior protection against hospitalization outcomes than standard-dose inactivated influenza vaccine (SD-IIV) among adults aged ≥65 years. Whether th...